Clinical trial
The Effects of Dietary Supplementation Allicor on Patients With Multifocal Atherosclerosis After Peripheral Artery Revascularization Treatment During a Year
NCT05813171 is registered in ClinicalTrials.gov with Institute for Atherosclerosis Research, Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Dietary Supplementation Allicor on Patients With Multifocal Atherosclerosis After Peripheral Artery Revascularization Treatment During a Year
- Lead sponsor
- Institute for Atherosclerosis Research, Russia
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 20, 2023
- Completion date
- May 31, 2024
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.